The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doyle Mittie since 2026.
This trader's CIK number is 1918845.
At the time of last reporting, Doyle Mittie was the Chief Medical Officer of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX).
Also see all insider trading activities at Avalo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | AVTX | 0 | $0 | 25,492 | $411,619 | 25,492 | $263,714 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-16 | AVTX | Option Ex | 25,492 | 10.35 | 263,714 |
| 2026-03-16 | AVTX | Sale | 25,492 | 16.15 | 411,619 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doyle Mittie (Chief Medical Officer of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.